La cadena de opciones muestra datos clave de las opciones de acciones de Fnac Darty a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Fnac Darty..

Fnac Darty (OTC:GRUPF) Bolsa, Cadena de Opciones

Fnac Darty SA is a retail distributor of entertainment and leisure products including consumer electronics in France, Spain, Portugal, Brazil, Belgium, Switzerland, and Morocco.

Fnac Darty SA

WIIM

AVGO

Broadcom shares are trading higher after the company announced the launch of the latest enhancements to VMware Tanzu CloudHealth.

Oppenheimer analyst Andreas Argyrides assumes Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) with a Outperform rating and announces Price Target of $19.

News

Price Target

Initiation

Analyst Ratings

ABEO

Oppenheimer Assumes Abeona Therapeutics at Outperform, Announces Price Target of $19

ATLN

Atlantic International Appoints Matt Evelt As COO, Effective Immediately

On August 15, 2025, Gray Media's local television station WANF will end its 31-year affiliation with the CBS Network to begin a new chapter as an independent television station. Going forward, WANF will leverage its successful local news operation, complete control of its daily program schedule, and the resources of the locally based Gray Media to better serve the local community with on-air and online content throughout the day that is more responsive to the growing Atlanta metropolis.

Gray Media's Local Television Station WANF To End 31-Year Affiliation With CBS Network On August 15, 2025 To Begin As Independent Television Station

<h3>Gainers</h3>
<ul>
<li>Classover Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KIDZ#NASDAQ">KIDZ</a>) stock moved upwards by 30.1% to $3.46 during Monday's regular session. The company's market cap stands at $81.9 million. </li>
<li>United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) shares moved upwards by 17.88% to $3.56. The market value of their outstanding shares is at $208.6 million. </li>
<li>Perfect Moment (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PMNT#AMEX">PMNT</a>) shares moved upwards by 17.18% to $0.75. </li>
<li>NWTN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NWTN#NASDAQ">NWTN</a>) shares increased by 16.99% to $1.79. The market value of their outstanding shares is at $512.2 million. </li>
<li>Red Robin Gourmet Burgers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RRGB#NASDAQ">RRGB</a>) shares rose 16.86% to $5.96. The company's market cap stands at $105.7 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) stock increased by 13.72% to $1.16. The market value of their outstanding shares is at $123.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>SharpLink Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBET#NASDAQ">SBET</a>) stock decreased by 38.1% to $47.5 during Monday's regular session. The company's market cap stands at $33.1 million. </li>
<li>High Roller Technologies (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ROLR#AMEX">ROLR</a>) stock decreased by 25.01% to $3.27. The market value of their outstanding shares is at $27.5 million. </li>
<li>ContextLogic (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LOGC#NASDAQ">LOGC</a>) stock declined by 17.02% to $6.8. The company's market cap stands at $181.5 million. </li>
<li>Allied Gaming (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AGAE#NASDAQ">AGAE</a>) stock fell 15.62% to $2.54. The company's market cap stands at $112.0 million. </li>
<li>QVC Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QVCGP#NASDAQ">QVCGP</a>) stock declined by 12.88% to $4.93. </li>
<li>LiveWire Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LVWR#NYSE">LVWR</a>) shares declined by 12.45% to $3.94. The market value of their outstanding shares is at $802.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

AGAE

CHGG

KIDZ

LOGC

LVWR

NWTN

PMNT

QVCGP

ROLR

RRGB

SBET

12 Consumer Discretionary Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Lyra Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYRA#NASDAQ">LYRA</a>) stock rose 376.8% to $23.5 during Monday's regular session. The market value of their outstanding shares is at $31.1 million. </li>
<li>Vera Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) stock increased by 64.08% to $31.09. The company's market cap stands at $1.9 billion. </li>
<li>ModivCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>) stock rose 59.82% to $1.79. The company's market cap stands at $25.6 million. </li>
<li>Hyperfine (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYPR#NASDAQ">HYPR</a>) shares rose 58.0% to $0.95. The company's market cap stands at $74.1 million. </li>
<li>Processa Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCSA#NASDAQ">PCSA</a>) stock moved upwards by 56.58% to $0.46. The company's market cap stands at $5.4 million. </li>
<li>Plus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTV#NASDAQ">PSTV</a>) shares moved upwards by 40.92% to $0.4. The company's market cap stands at $2.3 million. The company's, Q1 earnings came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Xilio Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XLO#NASDAQ">XLO</a>) stock declined by 31.2% to $0.74 during Monday's regular session. The company's market cap stands at $38.1 million. </li>
<li>Basel Medical Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMGL#NASDAQ">BMGL</a>) stock declined by 27.47% to $4.41. The company's market cap stands at $82.8 million. </li>
<li>BioLine Rx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) shares fell 19.24% to $4.24. The market value of their outstanding shares is at $15.7 million. The company's, Q1 earnings came out 4 days ago. </li>
<li>Verastem (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VSTM#NASDAQ">VSTM</a>) shares decreased by 18.82% to $6.11. The company's market cap stands at $335.4 million. </li>
<li>TherapeuticsMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXMD#NASDAQ">TXMD</a>) stock declined by 17.81% to $1.2. The market value of their outstanding shares is at $13.8 million. </li>
<li>Olema Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) stock fell 16.1% to $4.43. The market value of their outstanding shares is at $303.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BLRX

BMGL

HYPR

LYRA

MODV

OLMA

PCSA

PSTV

TXMD

VERA

VSTM

12 Health Care Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Hong Kong Pharma Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKPD#NASDAQ">HKPD</a>) stock increased by 103.4% to $2.38 during Monday's regular session. The company's market cap stands at $26.1 million. </li>
<li>CleanCore Solutions (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#AMEX">ZONE</a>) stock rose 72.27% to $3.79. The company's market cap stands at $30.1 million. </li>
<li>Lavoro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LVRO#NASDAQ">LVRO</a>) stock rose 61.15% to $4.19. The company's market cap stands at $488.5 million. </li>
<li>FGI Industries (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGI#NASDAQ">FGI</a>) shares increased by 45.36% to $0.79. The company's market cap stands at $7.5 million. </li>
<li>AgEagle Aerial Sys (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/UAVS#AMEX">UAVS</a>) shares moved upwards by 31.62% to $1.04. The company's market cap stands at $14.4 million. </li>
<li>374Water (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCWO#NASDAQ">SCWO</a>) stock increased by 29.5% to $0.56. The company's market cap stands at $81.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Zeo Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZEO#NASDAQ">ZEO</a>) stock fell 22.3% to $2.4 during Monday's regular session. The market value of their outstanding shares is at $54.7 million. As per the press release, Q4 earnings came out 4 days ago. </li>
<li>ESS Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWH#NYSE">GWH</a>) stock fell 19.41% to $1.37. The company's market cap stands at $16.5 million. </li>
<li>LanzaTech Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNZA#NASDAQ">LNZA</a>) shares decreased by 15.74% to $0.24. The company's market cap stands at $55.1 million. </li>
<li>Science Applications Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAIC#NASDAQ">SAIC</a>) shares declined by 13.24% to $100.25. The company's market cap stands at $4.7 billion. As per the press release, Q1 earnings came out today. </li>
<li>Huachen AI Parking Mgmt (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAI#NASDAQ">HCAI</a>) shares declined by 10.52% to $5.7. The market value of their outstanding shares is at $192.2 million. </li>
<li>Innovate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VATE#NYSE">VATE</a>) shares decreased by 9.0% to $5.26. The company's market cap stands at $69.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

HCAI

HKPD

LNZA

LVRO

SAIC

SCWO

UAVS

VATE

ZONE

12 Industrials Stocks Moving In Monday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) stock increased by 46.4% to $10.0 during Monday's regular session. The market value of their outstanding shares is at $2.2 billion. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares increased by 36.37% to $0.38. The company's market cap stands at $15.7 million. </li>
<li>Alpha Technology Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATGL#NASDAQ">ATGL</a>) stock rose 33.07% to $35.0. The company's market cap stands at $576.1 million. </li>
<li>CISO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CISO#NASDAQ">CISO</a>) shares moved upwards by 24.69% to $1.01. The market value of their outstanding shares is at $32.3 million. </li>
<li>WidePoint (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/WYY#AMEX">WYY</a>) stock rose 20.93% to $3.64. The company's market cap stands at $35.6 million. </li>
<li>Movano (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOVE#NASDAQ">MOVE</a>) stock moved upwards by 20.55% to $0.66. The market value of their outstanding shares is at $4.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>MicroAlgo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MLGO#NASDAQ">MLGO</a>) stock decreased by 12.3% to $1.28 during Monday's regular session. The company's market cap stands at $12.7 million. </li>
<li>SemiLEDs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) shares fell 12.09% to $2.62. The company's market cap stands at $18.8 million. </li>
<li>Upland Software (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPLD#NASDAQ">UPLD</a>) shares decreased by 11.54% to $1.91. The market value of their outstanding shares is at $54.4 million. </li>
<li>Yxt.Com Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YXT#NASDAQ">YXT</a>) stock declined by 11.05% to $0.85. The company's market cap stands at $51.3 million. </li>
<li>Pony AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) shares fell 10.86% to $17.17. The market value of their outstanding shares is at $6.1 billion. </li>
<li>Gryphon Digital Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRYP#NASDAQ">GRYP</a>) shares declined by 10.82% to $1.07. The market value of their outstanding shares is at $77.6 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLD

ATGL

BNAI

CISO

GRYP

LEDS

MLGO

MOVE

PONY

UPLD

12 Information Technology Stocks Moving In Monday's Intraday Session

CBS, a subsidiary of Paramount Global, and Gray Media (&quot;Gray&quot;) announced today that they have entered into an agreement that renews 52 of Gray&#39;s existing 53 CBS network affiliations. As part of the agreement, the renewing CBS affiliates will continue to be available locally to subscribers on Paramount+ and widely distributed across all traditional and virtual MVPD platforms. Effective August 16, 2025, Gray&#39;s Atlanta station WANF will cease its affiliation with the CBS Network and thereafter operate an independent television station hyper-focused on the Atlanta market.

PARA

Paramount Global's CBS And Gray Media Renew Affiliation Agreements For 52 Of Gray's Existing 53 CBS Network Affiliations

Foresight Diagnostics, a leading diagnostics company specializing in ultra-sensitive minimal residual disease (MRD) detection, today announced a strategic, worldwide partnership with QIAGEN (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QGEN#NYSE">QGEN</a>, Frankfurt Prime Standard: QIA))) to develop and commercialize a kit-based version of Foresight's CLARITY&#x2122; assay, with the goal of enabling global in vitro diagnostic (IVD) and companion diagnostic (CDx) applications in lymphoma and other hematological malignancies.
This collaboration combines Foresight's innovative MRD detection technology with QIAGEN's global leadership in molecular diagnostic development and commercialization. Together, the companies aim to lay the groundwork for a standardized, regulated diagnostic kit that, once validated and approved in pharmaceutical-sponsored trials, would be the only circulating tumor DNA (ctDNA)-based MRD assay available as both a central laboratory service and diagnostic kit capable of supporting clinical decision-making and therapeutic strategies for patients with hematological cancers.

QGEN

Foresight Diagnostics Partners With QIAGEN To Develop, Commercialize Kit-Based Version Of CLARITY Assay For Lymphoma

Trading Ideas

FTAI

CNBC Halftime Report Final Trades: Freeport-McMoRan, Cheniere Energy, FTAI Aviation, Box, Inc

<ul class="wp-block-list">
<li>JPMorgan Chase announced the opening of 14 new Financial Centers across four states this week</li>
<li>The brick-and-mortar locations are aimed at serving its Private Client tier, who have over $750,000 in qualifying deposits and investments with the institution</li>
<li>The new financial centers join to existing locations in San Francisco and New York City that opened late last year</li>
</ul>
JPMorgan Chase (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>) <a href="https://media.chase.com/news/jpmc-accelerates-affluent-offering-by-opening-14-new-financial-centers-in-four-states">announced</a> Tuesday it would be open 14 new financial centers to cater to affluent clients&nbsp; in four states this week.
These brick-and-mortar locations are spread out across California, Massachusetts, Florida, and New York. They will join the <a href="https://www.benzinga.com/news/large-cap/24/10/41388106/jpmorgan-launches-private-client-tier-to-attract-affluent-customers">two existing so-called&nbsp; J.P. Morgan Financial Centers</a> in San Francisco and New York City in servicing its wealthiest clientele.
"Through these Financial Centers, we are redefining how affluent clients are served, offering a highly personalized level of service that is backed by the global capabilities of J.P. Morgan Chase," Jennifer Roberts, CEO of Chase Consumer Banking, said in a statement.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
Each of the locations was acquired in May 2023 when the company took over First Republic. Situated in ritzy locales like Palm Beach, Florida; Napa, California; New York; and Cambridge, Massachusetts, the banks will feature private meeting spaces and distinctive finishes intended to create an environment of privacy, sophistication, and comfort.
Additionally, senior private client bankers will be on hand to provide personalized support for customers who qualify for the J.P. Morgan Private Client tier. These customers have over $750,000 in qualifying deposits and investment balances with the institution.&nbsp;
"When we meet with clients, they consistently say they want a relationship that spans across banking, lending, and investments, and provides a seamless experience as they navigate the complexities of managing and growing wealth," Roberts said. "These new Financial Centers offer a highly personalized service model, providing greater flexibility to meet clients&#8217; needs with exceptional attention and care."
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
JPMorgan Chase is <a href="https://www.jpmorganchase.com/content/dam/jpmc/jpmorgan-chase-and-co/investor-relations/documents/events/2025/jpmc-2025-investor-day/consumer-community-banking.pdf">the country's biggest bank</a> by deposits and assets, and has a top share in areas like retail credit cards. However, one area where it isn't a clear leader is wealth management.&nbsp;
Roberts told <a href="https://www.cnbc.com/2025/05/27/jpmorgan-chase-wealth-management.html">CNBC</a> that while JPMorgan Chase can count half of the 19 million affluent households in the U.S. as clients, it only has 10% of their investment dollars.
JPMorgan Chase hopes that these new Financial Centers, as well as the Private Client tier, will change that. "What First Republic did really well was deliver a concierge-level of service where if you have an issue, a person owned it for you and you didn't have to worry about it," Roberts told CNBC. "So with this experience, we are going to deliver a more elevated concierge type of service, like you would expect at a high-end hotel."
"We want people walking in, having the experience, meeting with our experts and understanding how we can help support their financial goals over time," she said.
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
</ul>
Image: Shutterstock

Personal Finance

JPMorgan Chase To Open New 'Elevated Concierge Type Of Service' Brick-And-Mortar Locations To Woo Wealth Clientele

Oppenheimer analyst Andreas Argyrides assumes Dyne Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYN#NASDAQ">DYN</a>) with a Outperform rating and lowers Price Target of $34.

Oppenheimer Assumes Dyne Therapeutics at Outperform, Lowers Price Target of $34

Whales with a lot of money to spend have taken a noticeably bullish stance on Hims &amp; Hers Health.
Looking at options history for Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) we detected 36 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 11 are puts, for a total amount of $666,345 and 25, calls, for a total amount of $1,205,747.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $3.0 and $90.0 for Hims &amp; Hers Health, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Hims &amp; Hers Health's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Hims &amp; Hers Health's whale trades within a strike price range from $3.0 to $90.0 in the last 30 days. 
<h3>Hims &amp; Hers Health Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748883673_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$13.6</td>
<td>$13.4</td>
<td>$13.5</td>
<td>$55.00</td>
<td>$135.0K</td>
<td>250</td>
<td>105</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$8.45</td>
<td>$8.3</td>
<td>$8.45</td>
<td>$65.00</td>
<td>$119.1K</td>
<td>2.6K</td>
<td>529</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>08/15/25</td>
<td>$8.85</td>
<td>$8.75</td>
<td>$8.75</td>
<td>$55.00</td>
<td>$119.0K</td>
<td>5.7K</td>
<td>252</td>
</tr>
<tr>
<td>HIMS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$2.34</td>
<td>$2.21</td>
<td>$2.34</td>
<td>$28.00</td>
<td>$107.4K</td>
<td>1.2K</td>
<td>1.2K</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$32.0</td>
<td>$31.95</td>
<td>$32.0</td>
<td>$30.00</td>
<td>$96.0K</td>
<td>204</td>
<td>57</td>
</tr>
</tbody>
</table>

<h3>About Hims &amp; Hers Health</h3>
Hims &amp; Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
Having examined the options trading patterns of Hims &amp; Hers Health, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Hims &amp; Hers Health</h3>
<ul>
<li>With a volume of 22,579,930, the price of HIMS is up 1.73% at $57.54. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 63 days.</li>
</ul>
<h3>Expert Opinions on Hims &amp; Hers Health</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $43.33.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Needham has revised its rating downward to Buy, adjusting the price target to $61. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Neutral, adjusting the price target to $39. 
&#x2A; An analyst from Citigroup persists with their Sell rating on Hims &amp; Hers Health, maintaining a target price of $30. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Hims &amp; Hers Health, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Hims & Hers Health, Inc. Class A Common Stock

HIMS

Check Out What Whales Are Doing With HIMS

Deep-pocketed investors have adopted a bullish approach towards Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in XYZ usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Block. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 46% leaning bullish and 46% bearish. Among these notable options, 3 are puts, totaling $94,450, and 10 are calls, amounting to $409,306.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $25.0 to $90.0 for Block during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Block options trades today is 1046.18 with a total volume of 1,590.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Block's big money trades within a strike price range of $25.0 to $90.0 over the last 30 days.
<h3>Block Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748883668_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$8.95</td>
<td>$8.85</td>
<td>$8.95</td>
<td>$52.50</td>
<td>$89.4K</td>
<td>2.6K</td>
<td align="right">105</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$39.95</td>
<td>$38.8</td>
<td>$39.42</td>
<td>$25.00</td>
<td>$47.2K</td>
<td>175</td>
<td align="right">60</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$12.9</td>
<td>$11.9</td>
<td>$12.55</td>
<td>$65.00</td>
<td>$43.9K</td>
<td>726</td>
<td align="right">35</td>
</tr>
<tr>
<td>XYZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$3.9</td>
<td>$3.8</td>
<td>$3.8</td>
<td>$90.00</td>
<td>$43.7K</td>
<td>1.4K</td>
<td align="right">116</td>
</tr>
<tr>
<td>XYZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$1.25</td>
<td>$1.19</td>
<td>$1.25</td>
<td>$60.00</td>
<td>$39.6K</td>
<td>1.1K</td>
<td align="right">458</td>
</tr>
</tbody>
</table>

<h3>About Block</h3>
Founded in 2009, Block provides payment services to merchants, along with related services. The company also launched Cash App, a person-to-person payment network. In 2024, Square's payment volume was almost USD 250 million.
After a thorough review of the options trading surrounding Block, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Block</h3>
<ul>
<li>Currently trading with a volume of 2,867,635, the XYZ's price is down by -0.23%, now at $61.61. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 59 days.</li>
</ul>
<h3>Expert Opinions on Block</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $59.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from BMO Capital lowers its rating to Market Perform with a new price target of $58. 
&#x2A; An analyst from Macquarie downgraded its action to Neutral with a price target of $50. 
&#x2A; An analyst from Truist Securities has revised its rating downward to Sell, adjusting the price target to $60. 
&#x2A; An analyst from Jefferies persists with their Buy rating on Block, maintaining a target price of $70. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Block with a target price of $57. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Block options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

A Closer Look at Block's Options Market Dynamics

Whales with a lot of money to spend have taken a noticeably bullish stance on Palantir Technologies.
Looking at options history for Palantir Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) we detected 121 trades.
If we consider the specifics of each trade, it is accurate to state that 42% of the investors opened trades with bullish expectations and 40% with bearish.
From the overall spotted trades, 21 are puts, for a total amount of $1,213,618 and 100, calls, for a total amount of $7,402,108.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75.0 to $200.0 for Palantir Technologies over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Palantir Technologies's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Palantir Technologies's whale activity within a strike price range from $75.0 to $200.0 in the last 30 days. 
<h3>Palantir Technologies Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748883662_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$17.2</td>
<td>$16.85</td>
<td>$16.85</td>
<td>$114.00</td>
<td>$589.7K</td>
<td>3.1K</td>
<td>1.9K</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$16.8</td>
<td>$16.65</td>
<td>$16.65</td>
<td>$140.00</td>
<td>$499.5K</td>
<td>3.3K</td>
<td>908</td>
</tr>
<tr>
<td>PLTR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/06/25</td>
<td>$12.55</td>
<td>$12.2</td>
<td>$12.23</td>
<td>$119.00</td>
<td>$428.0K</td>
<td>3.3K</td>
<td>1.5K</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$18.7</td>
<td>$18.65</td>
<td>$18.7</td>
<td>$105.00</td>
<td>$233.7K</td>
<td>364</td>
<td>14</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/17/27</td>
<td>$41.0</td>
<td>$40.55</td>
<td>$40.9</td>
<td>$125.00</td>
<td>$204.5K</td>
<td>851</td>
<td>402</td>
</tr>
</tbody>
</table>

<h3>About Palantir Technologies</h3>
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.
Having examined the options trading patterns of Palantir Technologies, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Palantir Technologies Standing Right Now?</h3>
<ul>
<li>With a trading volume of 61,879,103, the price of PLTR is down by -0.02%, reaching $131.75.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 63 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Palantir Technologies</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $108.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from DA Davidson keeps a Neutral rating on Palantir Technologies with a target price of $115. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Neutral rating on Palantir Technologies, which currently sits at a price target of $90. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Underperform rating on Palantir Technologies with a target price of $94. 
&#x2A; An analyst from Loop Capital persists with their Buy rating on Palantir Technologies, maintaining a target price of $130. 
&#x2A; An analyst from Citigroup has decided to maintain their Neutral rating on Palantir Technologies, which currently sits at a price target of $115. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Palantir Technologies with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

PLTR

Market Whales and Their Recent Bets on PLTR Options

We've discussed exhaustively how&nbsp;<a href="https://www.tker.co/p/few-stocks-drive-long-term-returns">difficult it is to pick stocks that outperform</a>&nbsp;the market.
But let's assume you were able to identify these winning stocks. Is it smooth sailing from there as you&nbsp;<a href="https://www.tker.co/p/spiva-2024-active-managers-underperform-benchmark">smoke the competition</a>?
No. Far from it.
It turns out that the stocks offering the best returns for investors historically experienced incredibly painful max drawdowns (i.e. percentage declines from a price peak to a trough).
Morgan Stanley's Michael Mauboussin and Dan Callahan recently&nbsp;<a href="https://www.morganstanley.com/im/en-us/individual-investor/insights/articles/drawdowns-and-recoveries.html">studied</a>&nbsp;the price behavior of 6,500 stocks. Among other things, they took a closer look at the 20 stocks with the best total shareholder returns over the 40-year period from 1985 to 2024. They also reviewed the performance of the 20 worst performers during the period. (Note: They only considered stocks listed on the NYSE, NASDAQ and NYSE American exchanges that traded during the entire measurement period. They excluded companies worth less than $1 billion at the beginning and $250 million at the end of their maximum drawdowns.)
"The median maximum drawdown was 72% for the best group, and the median maximum drawdown duration, the time from peak to trough, was 2.9 years," they found. "The median time to return to the prior peak was 4.3 years. The median annualized abnormal returns following the bottom was 8% for the next 5 years and 12% for the next 10 years. This is based on the unrealistic assumption the stock was purchased at the low."
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9e369a1f-6d7d-4415-ab9c-80d6bce8e06f_1488x964.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2F9e369a1f-6d7d-4415-ab9c-80d6bce8e06f_1488x964.png" alt="" /></a><figcaption class="wp-element-caption">The best performing stocks in the market experience massive drawdowns that can last years. (Source: Morgan Stanley)</figcaption></figure>
Just&nbsp;<a href="https://www.tker.co/p/market-economic-crisis-history">thinking about</a>&nbsp;one of my positions losing 72% of its value makes me queasy, even knowing full well this is the average behavior of the best stocks.
Now imagine being a fund manager with the conviction to hang on to these types of stocks.
Mauboussin and Callahan note that Alpha Architect's Wes Gray considered this thought experiment in a paper titled: "<a href="https://alphaarchitect.com/even-god-would-get-fired-as-an-active-investor/">Even God Would Get Fired as an Active Investor.</a>"
"[Gray's] point is that if you had the (godlike) foresight to build a portfolio of the stocks that would produce the highest TSRs over the next five years, you would have ‘great returns, but gut-wrenching drawdowns,'" they wrote. "In other words, the drawdowns are so large that a client who hired you to be their active manager might fire you."
<h2 class="wp-block-heading">Investing in index funds has its benefits &#x1f44d;</h2>
The analysts considered the performance of the S&amp;P 500 over this measurement period to show the benefits of diversification.
"The maximum drawdown for the index was 58%, the maximum drawdown duration was 1.4 years, and the time to recover back to par was 4.2 years," they observed. "Following the trough, the annual TSR for the S&amp;P 500 was 25% over 5 years and 17% over 10 years."
So maybe your return isn't as high as investing in the top performing stocks. But the max drawdown for the S&amp;P is shallower, and the duration of that drawdown is much shorter.
Obviously, you'd still opt for the more painful drawdowns if you knew you would outperform the market over time.
Unfortunately, almost no one has a consistent track record of identifying those long-term winners. And there are a lot of stocks with underperforming returns, including a whole lot of stocks that never recover from their max drawdowns.
"The median stock's recovery from its maximum drawdown is 90% of the prior peak price (par), which means it fails to return to its past high," they found. "In fact, about 54% of stocks never return to par after hitting bottom." (Note: For this review, they considered stocks listed on the NYSE, NASDAQ and NYSE American exchanges that traded during the entire measurement period. They only considered stocks that worth worth at least $1 million at the end of any month.)
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd640b524-cb1e-40f8-b9a7-77dc1cc0e8e0_1546x448.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd640b524-cb1e-40f8-b9a7-77dc1cc0e8e0_1546x448.png" alt="" /></a><figcaption class="wp-element-caption">The median stock gets crushed, and most most stocks never fully recover from their drawdowns. (Source: Morgan Stanley)</figcaption></figure>
One of the more notable findings in this study is that the average recovery from a drawdown is a whopping 338.5%, to which the analysts said: "This tells you that some stocks produced very high returns off of the bottom."
Indeed, a few stocks —&nbsp;<a href="https://www.tker.co/p/few-stocks-drive-long-term-returns">some generating &gt;1,000% returns</a>&nbsp;— can be responsible for the&nbsp;<a href="https://www.tker.co/p/few-stocks-drive-long-term-returns">bulk of a portfolio's returns</a>.
To put it another way, the&nbsp;median&nbsp;89.5% recovery figure tells us it's very hard to pick winning stocks. Meanwhile, the&nbsp;average&nbsp;338.5% recovery figure tells us that a broadly diversified portfolio with exposure to all stocks can generate returns that multiply the value of your initial investment.
<h2 class="wp-block-heading">It takes a strong stomach&#x1fac4;&#x1f3fb;</h2>
Legendary stock picker Peter Lynch once said: &#8220;In the stock market, the most important organ is the stomach. It&#8217;s not the brain."
This is true for investors in broadly diversified index funds. This is even more true for investors who aim to pick stocks with the aim of producing market-beating returns.
&#8211;

Equities

Long Ideas

Broad U.S. Equity ETFs

Opinion

Identifying Winning Stocks Is Hard. Holding Winning Stocks Is A Nightmare

Viper Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NYSE">VNOM</a>) short percent of float has risen 12.6% since its last report. The company recently reported that it has 7.00 million shares sold short, which is 15.46% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.25 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Viper Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748883629_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Viper Energy has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Viper Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Viper Energy's peer group average for short interest as a percentage of float is 7.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

VNOM

How Is The Market Feeling About Viper Energy?

Tesla's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NYSE">TSLA</a>) short percent of float has risen 4.48% since its last report. The company recently reported that it has 85.02 million shares sold short, which is 3.03% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Tesla Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748883624_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tesla has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Tesla's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Tesla's peer group average for short interest as a percentage of float is 8.02%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TSLA

What Does the Market Think About Tesla?

In the current market session, Southwest Airlines Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) stock price is at $32.98, after a 1.21% drop. However, over the past month, the company's stock spiked by 10.51%, and in the past year, by 18.62%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1748883619_0_0.png" alt="Past Year Chart" />

<h3>Evaluating Southwest Airlines P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of 10.7 in the Passenger Airlines industry, Southwest Airlines Inc. has a higher P/E ratio of 37.51. Shareholders might be inclined to think that Southwest Airlines Inc. might perform better than its industry group. It's also possible that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1748883619_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

A Look Into Southwest Airlines Inc's Price Over Earnings

Fnac Darty

Comments

Fnac Darty

Fnac Darty (GRUPF) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL